{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:27:14Z","timestamp":1758400034101,"version":"3.40.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The Deutsche Apotheker Zeitung (DAZ, German Pharmacist Journal) is an independent pharmaceutical newspaper focusing on science and practice, mainly for the profession of pharmacist. In this study, drug advertising in the DAZ was analysed. To our knowledge, there is little scientific data available on drug advertising in professional journals. We assumed that professional journals provide particularly good background information on the advertised drugs because they are targeted to specialists. All non-prescription medicines and preparations that fall under the Medicines Advertising Law (Heilmittelwerbegesetz, HWG) were studied. The Medicines Advertising Law regulates the legal procedure for advertising medicinal products in Germany. The 167 product advertisements from the 52 issues of 2021 were analysed and checked for compliance with the Medicines Advertising Law. We identified significant deficiencies in compliance with the legislation. These included the lack of mandatory information required by the Medicines Advertising Law, for example the indication of adverse drug reactions and the listing of contraindications. There are very few peer-reviewed references on the efficacy of the advertised preparations. A scientific validation was carried out using the PubMed database, with the result that scientific information was available only for 1\/3 of the advertisements. In addition, the appearance and target groups as well as social structures, images and feelings conveyed by the advertising were analysed. This study provides insights into the mechanisms of drug advertising in professional journals, which have not yet been researched to any great extent. Even in professional journals, pharmacological evidence plays a much smaller role than marketing, psychology and traditional social values. It seems that drug manufacturers deliberately ignore the German Medicines Advertising Law to advertise their products in the best possible way. Stricter legal controls should be put in place to prevent this practice and protect consumers from misinformation. This will increase drug safety.<\/jats:p>","DOI":"10.1007\/s00210-024-03401-3","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:04:51Z","timestamp":1726149891000},"page":"2739-2751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advertisements for prescription-free drugs and dietary supplements in the Deutsche Apotheker Zeitung (German Pharmacist Journal)"],"prefix":"10.1007","volume":"398","author":[{"given":"Kristian","family":"Kuschel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"4","key":"3401_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/07359683.2016.1238262","volume":"33","author":"KJ Aikin","year":"2016","unstructured":"Aikin KJ, Sullivan HW, O\u2019Donoghue AC (2016) Betts KR (2016) Consumer perceptions of prescription and over-the-counter drug advertisements with promotional offers. Health Mark Q. 33(4):291\u2013306. https:\/\/doi.org\/10.1080\/07359683.2016.1238262","journal-title":"Health Mark Q."},{"key":"3401_CR2","doi-asserted-by":"publisher","unstructured":"Bignardi, Paulo R et al. (2023) Is the vitamin D status of patients with COVID-19 associated with reduced mortality? A Systematic Rev Meta-analysis. https:\/\/doi.org\/10.20945\/2359-3997000000588","DOI":"10.20945\/2359-3997000000588"},{"key":"3401_CR3","doi-asserted-by":"crossref","unstructured":"Cartes C, Segovia C, Salinas.Toro D, Goja C, Alonso M, Lopez-Solis Remigio, Zapata C, Cabezas M, Ya\u00f1ez P, Flores-Rodriguez P, Lopez D, Matus G, Traipe L (2021) Dry eye and visual display terminal-related symptoms among university students during the coronavirus disease pandemic. Ophthalmic Epidemiol 29:245-251","DOI":"10.1080\/09286586.2021.1943457"},{"key":"3401_CR4","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.3390\/ijerph20043050","volume":"20","author":"J Chim","year":"2023","unstructured":"Chim J, Chen T (2023) Prediction of work from home and musculoskeletal discomfort: an investigation of ergonomic factors in work arrangements and home workstation setups using the COVID-19 experience. Int J Environ Res Public Health 20:3050","journal-title":"Int J Environ Res Public Health"},{"key":"3401_CR5","unstructured":"Evans J (2017) Bunt heilt schneller. Pharmazeutische Zeitung. Retrieved April 10, 2024, from. https:\/\/www.pharmazeutische-zeitung.de\/ausgabe-302017\/bunt-heilt-schneller\/"},{"key":"3401_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12889-021-10582-6","volume":"21","author":"D Hallman","year":"2021","unstructured":"Hallman D, Januario L, Mathiassen S, Heiden M, Svensson S, Bergstr\u00f6m G (2021) Working from home during the COVID-19 outbreak in Sweden: effects on 24-h time-use in office workers. BMC Public Health 21:528","journal-title":"BMC Public Health"},{"key":"3401_CR7","unstructured":"Huber DS (2012) Arzneimittelwerbung: Gesetzliche Lockerungen durch HWG-Novelle https:\/\/www.it-recht-kanzlei.de\/werbung-arzneimittel-hwg-novelle.html"},{"key":"3401_CR8","unstructured":"Kalb S (2004) Kann eine Beeinflussung des Arztes durch Arzneimittelwerbung seinem Ziel, einem handeln im Interesse des Patienten, entgegenstehen? [Influence of pharmaceutical advertising on the physician. A contribution to ethics in medicine]. Wurzbg Medizinhist Mitt. 2004;23:446\u201356. German"},{"key":"3401_CR9","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s00210-023-02744-7","volume":"397","author":"L Keuper","year":"2024","unstructured":"Keuper L, Seifert R (2024) Drug advertising in the German free-of-charge health magazine Apotheken Umschau (Pharmacy review): a critical analysis. Naunyn Schmiedebergs Arch Pharmacol 397:2145\u20132157. https:\/\/doi.org\/10.1007\/s00210-023-02744-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3401_CR10","unstructured":"Knierim A (2023) EU-Pharma-Paket: Was \u00e4ndert sich in der Arzneimittelwerbung? https:\/\/www.taylorwessing.com\/de\/insights-and-events\/insights\/2023\/06\/eu-pharma-paket"},{"key":"3401_CR11","doi-asserted-by":"crossref","unstructured":"Ludwig W, M\u00fchlbauer B, Seifert R (2023) Arzneiverordnungs-Report 2022, vol.347. Springer, Berlin\/Heidelberg, pp 87\u2013409","DOI":"10.1007\/978-3-662-66303-5_41"},{"key":"3401_CR12","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/bcp.13656","volume":"84","author":"JC McCrae","year":"2018","unstructured":"McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ (2018) Long-term adverse effects of paracetamol \u2013 a review. Br J Clin Pharmacol 84:2218\u20132230","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3401_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/1389200220666190325141422","volume":"20","author":"MK Parvez","year":"2019","unstructured":"Parvez MK (2019) Herb-Drug Interactions and Hepatotoxicity. Curr Drug Metab 20(4):275\u2013282. https:\/\/doi.org\/10.2174\/1389200220666190325141422","journal-title":"Curr Drug Metab"},{"key":"3401_CR14","unstructured":"Puteanus U (2000) Arzneimittelwerbung-Verbraucher wollenInformation. https:\/\/www.thieme-connect.com\/products\/ejournals\/abstract\/10.1055\/s-2000-13038"},{"issue":"2","key":"3401_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/FTD.0000000000000924","volume":"44","author":"O Scherf-Clavel","year":"2022","unstructured":"Scherf-Clavel O (2022) Drug-drug interactions with over-the-counter medicines: mind the unprescribed. Ther Drug Monit 44(2):253\u2013274. https:\/\/doi.org\/10.1097\/FTD.0000000000000924","journal-title":"Ther Drug Monit"},{"issue":"2","key":"3401_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3122\/jabfm.2020.02.190278","volume":"3","author":"HW Sullivan","year":"2020","unstructured":"Sullivan HW, Aikin KJ, Berktold J, Stein KL, Hoverman VJ (2020) Direct-to-consumer prescription drug advertising and patient-provider interactions. J Am Board Fam Med. 3(2):279\u2013283. https:\/\/doi.org\/10.3122\/jabfm.2020.02.190278","journal-title":"J Am Board Fam Med."},{"issue":"6","key":"3401_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/bcp.13573","volume":"84","author":"PN Taylor","year":"2018","unstructured":"Taylor and\u00a0Davies\u00a0(2018) Davies JS (2018) A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol 84(6):1121\u20131127. https:\/\/doi.org\/10.1111\/bcp.13573","journal-title":"Br J Clin Pharmacol"},{"key":"3401_CR18","unstructured":"Trabert M, Seifert R (2023) Kritische Analyse von Ginko-Pr\u00e4paraten: Vergleich der in Deutschland zugelassenen Arzneimittel und Nahrungserg\u00e4nzungsmittel. Naunyn-Schmiedeberg Arch Pharmacol (im Druck)"},{"key":"3401_CR19","unstructured":"Tr\u00f6bitscher N (2023) Apotheken sollen Werbemittel pr\u00fcfen (2023) https:\/\/www.apotheke-adhoc.de\/nachrichten\/detail\/politik\/apotheken-sollen-werbemittel-pruefen\/"},{"key":"3401_CR20","doi-asserted-by":"publisher","unstructured":"Tuffs A (2004) Only 6% of drug advertising material is supported by evidence BMJ 2004; 328. https:\/\/doi.org\/10.1136\/bmj.328.7438.485-a.\u00a0Published 27 February 2004","DOI":"10.1136\/bmj.328.7438.485-a"},{"key":"3401_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(03)12118-6","volume":"361","author":"P Villanueva","year":"2003","unstructured":"Villanueva P, Peir\u00f3 S, Librero J (2003) Pereir\u00f3 I (2003) Accuracy of pharmaceutical advertisments in medical journals. Lancet 361:27\u201332","journal-title":"Lancet"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03401-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03401-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T10:46:24Z","timestamp":1742294784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03401-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3401"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03401-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted according to the guidelines of good scientific practice of the Hannover Medical School () and officially registered as doctoral thesis project for Kristian Kuschel. The Hannover Medical School follows the guidelines of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable because publicly available information is used as data source.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and adheres to the editorial policies of the journal for editors acting as authors ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}